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called PhTX-I, puriﬁed from Porthidium hyoprora venom by one step analytical chromatography reverse phase
HPLC. The homogeneity of the PhTX-I fraction and its molecular mass were initially evaluated by SDS–PAGE
and conﬁrmed by MALDI-TOF spectrometry, indicating a molecular mass of 14.249 Da and constituted of a
single polipeptidic chain. Amino acid sequence was determined by “de novo sequencing,” in tandem mass
spectrometry, belonging to D49-PLA2 enzyme class and exhibiting high identity (44–90%) with other
myotoxics PLA2 from snake venoms. The enzymatic investigation showed maximal activity at pH 8 and 35–
45 °C. This activity was dependent on Ca2+, other cations (Mg2+, Mn2+, Cd2+ and Zn2+) reduced notably the
enzymatic activity, suggesting that the arrangement of the catalytic site presents an exclusive structure for
Ca2+. Ex vivo, whole venom and PhTX-I PLA2 caused blockade of the neuromuscular transmission in young
chick biventer cervicis preparations similar to other isolated snake venom toxins from the Bothrops genus. In
vivo, both induced local myotoxicity and systemic interleukin-6 response upon intramuscular injection,
additionally, induced moderate footpad edema. In vitro, both induced low cytotoxicity in skeletal muscle
myoblasts, however PhTX-I PLA2 was able to lyse myotubes.stry, Institute of Biology, State
ode 13083–970, Campinas, SP,
e-Soto).
vier OA license. © 2011 Elsevier Inc. Open access under the Elsevier OA license. 1. Introduction
Snake venoms comprise a complex pool of proteins (more than 90%
of the dry weight), organic compounds with low molecular mass and
inorganic compounds. Among the toxic compounds are included
proteins such as desintegrins and bradykinin-potentiating peptides
and enzymes such as metalloproteases, serinoproteases and phospho-
lipases, etc. Among these bioactive proteins, myotoxins phospholipases
A2 (PLA2 E.C 3.1.1.4) are the main components (Serrano et al., 2005).
PLA2 are calcium-dependent enzymes and catalyzes the selective
hydrolysis of the sn-2 acyl ester bond in 1,2-diacyl-sn-glycero-3
phospholipids, resulting in the formation of free fatty acids, such as
arachidonic acid and lysophospholipids (Burke and Dennis, 2009).
These lipids are also substrates for intracellular biochemical pathways
that generate potent autocrine and paracrine lipid mediators such as
the eicosanoids and platelet activating factor (Brash, 2001; Jensen
et al., 2005; Jenkins et al., 2009).
The superfamily of PLA2 has been classiﬁed into 15 groups
(Schaloske and Dennis, 2006). Based on the amino acid sequencesand cell location analysis, snake venom phospholipases A2 belong to
group I (elapid snakes) or II (viperid and crotalid snakes) species.
Snake venom PLA2 are interesting proteins, containing about 120–130
amino acids, that are cross-linked by seven disulﬁde bonds. In
addition to their catalytic activity, this PLA2 displays an array of
biological actions which may be either dependent or independent of
catalysis, including: myotoxicity, neurotoxicity, hypotensive, antico-
agulant, platelet-aggregation inhibition and edema inducing activities
(Kini, 2003; Magro et al., 2004; Tsai et al., 2004).
The biology and the biochemistry of a lot of PLA2 from bothropic
and crotalic venoms have been documented; however, there is
scantiness of information about the phospholipases A2 of Porthidium
hyoprora snake venom, a poisonous snake that belongs to the family
Viperidae, widely spread in the Amazonian area of Brazil, Ecuador,
Peru and Colombia, (Campbell and Lamar, 2004). Studies on clinical
and epidemiological features of Bothrops, Porthidium and Botriechis
snakebites showed that edematogenic, hemorrhagic and necrosis-
inducing activities of P. hyoprora venom were similar to Bothrops
species (Campos et al., 1999; Otero et al., 2002). Some clinicians prefer
to use the term “bothropic envenomation” because the clinical effects
of those venoms are generally similar. Thus, pharmacological studies
involving PLA2 puriﬁed from this venom are required, since they are
the main venom components responsible for muscular necrosis and
inﬂammatory responses in snakebites (Gutiérrez and Lomonte, 1997;
Kini, 2003).
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characterization including ex vivo neurotoxicity on young chicken
biventer cervicis preparations, inﬂammatory activities in the footpad
of mice, in vivo myotoxicity and in vitro cytotoxicity of a novel PLA2
named PhTX-I from P. hyoprora venom.
2. Material and methods
2.1. Venom and reagents
The venom and the solvents (HPLC grade), 4-nitro-3-(octanoyloxy)
benzoic acid, sequence grade bovine pancreatic trypsin and other
reagents were from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA).
2.2. Reverse Phase HPLC (RP-HPLC)
The PhTX-I PLA2 from P. hyoprora venom was puriﬁed by reverse
phase HPLC according to method described by Ponce-Soto et al.
(2007) using 500 mg of whole venom. Brieﬂy, 5 mg of whole venom
was dissolved in 200 μL of buffer A (0.1% TFA) and centrifuged at
4500 g, the supernatant was then applied to a μ-Bondapack C18
column (0.78×30 cm; Waters 991-PDA system), previously equili-
brated with buffer A for 15 min. The elution of the protein was then
conducted using a linear gradient (0–100%, v/v) of buffer B (66.5%
acetronitrile in buffer A) at a constant ﬂow rate of 1.0 mL/min. The
chromatographic run was monitored at 280 nm of absorbance and
after elution the fraction was lyophilized and stored at −40 °C.
2.3. Electrophoresis
Tricine SDS–PAGE in a discontinuous gel and buffer systemwas used
to estimate the molecular mass of the PhTX-I PLA2, under reducing and
non-reducing conditions (Schagger and Von Jagow, 1987). The
molecular mass markers used were (in kDa): phosphorylase B — 94,
albumin — 67, ovalbumin — 43, carbonic anhydrase — 30, soybean
trypsin inhibitor — 20 and lysozyme — 14.
2.4. Amino acid analysis
Amino acid analysis was performed on a Pico-Tag Analyzer
(Waters Systems) as described by Heinrikson and Meredith (1984).
PhTX-I PLA2, sample (30 μg) was hydrolyzed at 105 °C for 24 h, in 6 M
HCl (Pierce sequencing grade) containing 1% phenol (w/v). The
hydrolyzates were reacted with 20 μL of derivatization solution
(ethanol:triethylamine:water:phenylisothiocyanate, 7:1:1:1, v/v) for
1 h at room temperature, after which the PTC-amino acids were
identiﬁed and quantiﬁed by HPLC, by comparing their retention times
and peak areas with those from a standard amino acid mixture.
2.5. Reduction and alkylation
Puriﬁed lyophilized protein PhTX-I PLA2 from RP-HPLC was
resuspended in 8 M urea containing 10 mM DTT at pH 8.0 and the
disulﬁde bridges were then reduced by incubation at 37 °C for 2 h.
Iodoacetamide was used for alkylating the free thiols of cysteine
residues, based on previous experiments, a 30% molar excess of
iodoacetamide relative to the total number of thiols was eventually
chosen and the mixture was incubated for 1.5 h at 37 °C in the dark.
The reaction was stopped by injecting the mixture onto a RP-HPLC
column followed by lyophilization of the collected peak.
2.6. Enzymatic hydrolysis
The puriﬁed protein PhTX-I PLA2 was hydrolysed with sequencing
grade bovine pancreatic trypsin in 0.4% ammonium bicarbonate,pH 8.5, for 4 h at 37 °C, at an enzyme:substrate ratio of 1:100 (w/w).
The reaction was ceased by lyophilization.
2.7. Mass spectrometry
The molecular mass of intact native and alkylated PhTX-I PLA2
were analyzed by MALDI-TOF mass spectrometry using a Voyager-DE
PRO MALDI-TOF apparatus (Applied Biosystems, Foster City, CA, USA)
equipped with a pulsed nitrogen laser (337 nm, pulse with 4 ns). 1 μL
of sample in 0.1% TFA wasmixed with 2 μL of the matrix sinapinic acid
(3, 5-dimethoxy-4-hydroxycinnamic acid). The matrix was prepared
with 30% acetonitrile and 0.1% TFA and its mass analyzed under the
following conditions: accelerate voltage 25 kV, the laser ﬁxed in
2890 μ J/com2, delay 300 ns, and linear analysis mode (Ponce-Soto
et al., 2006).
ESI-CID-MS/MS analyses were performed using a quadrupole-time
of ﬂight (Q-TOF) hybrid mass spectrometer Q-TOF Ultima from
Micromass (Manchester, UK) equipped with a nano Zspray source
operating in a positive ion mode. The ionization conditions of usage
included a capillary voltage of 2.3 kV, a cone voltage and RF1 lens of
30 V and 100 V, respectively, and a collision energy of 10 eV. The
source temperature was 70 °C and the cone gas was N2 at a ﬂow of
80 l/h; nebulizing gas was not used to obtain the sprays. Argon was
used for collisional cooling and for fragmentation of ions in the
collision cell. External calibrationwith sodium iodidewasmade over a
mass range from 50 to 3000 m/z. All spectra were acquired with the
TOF analyser in “Vmode” (TOF kV=9.1) and the MCP voltage set at
2150 V (Damico et al., 2005).
2.8. De novo sequencing of tryptic peptides
Alkylated tryptic peptides from PhTX-I PLA2 were fractionated by
RP-HPLC, collected manually, lyophilized and re-suspended in 80%
H2O and 20% acetonitrile in 0.1% TFA. Each peptide was introduced
separately into the mass spectrometer source with a syringe pump at
a ﬂow-rate of 500 nl/min−1. Before performing a tandem mass
spectrum, an ESI/MS mass spectrum (TOF MS mode) was acquired for
each HPLC fraction over the mass range of 400–2000 m/z, in order to
select the ion of interest, subsequently, these ions were fragmented in
the collision cell (TOFMS/MSmode). Different collision energies were
used, depending on the mass and charge state of the ions. The
resulting product-ion spectra were acquired in the TOF analyser and
deconvoluted using the MassLynx-MaxEnt 3 algorithm. Singly
charged spectra were processed manually using the PepSeq applica-
tion included in MassLynx.
2.9. PLA2 activity
PLA2 activity was measured using the assay described by Cho and
Kezdy (1991) and Holzer and Mackessy (1996) modiﬁed for 96-well
plates. The standard assay mixture contained 200 μL of buffer (10 mM
Tris–HCl, 10 mM CaCl2 and 100 mM NaCl, pH 8.0), 20 μL of substrate
4-nitro-3-(octanoyloxy) benzoic acid (3 mM), 20 μL of water and
20 μL of PhTX-I PLA2 (1 mg/mL) in a ﬁnal volume of 260 μL. After
adding PhTX-I PLA2, respectively (20 μg), the mixture was incubated
for up to 40 min at 37 °C, with the reading of absorbance at intervals of
10 min. The enzyme activity, expressed as the initial velocity of the
reaction (Vo), was calculated based on the increase of absorbance after
20 min. The pH and optima temperature of the PLA2 were determined
by incubating the enzyme in four buffers of different pH values (4–10)
and in Tris–HCl buffer, pH 8.0, at different temperatures, respectively.
The effect of substrate concentration (40, 20, 10, 5, 2.5, 1.0, 0.5, 0.3, 0.2
and 0.1 mM) on enzyme activity was determined by measuring the
increase of absorbance after 20 min of incubation in Tris–HCl buffer,
pH 8.0, at 37 °C. All assays were done in triplicate and the absorbances
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reader (Molecular Devices, Sunnyvale, CA).
2.10. Chick biventer cervicis muscle preparation (BCp)
Animals were anesthetized with halothane and sacriﬁced by
exsanguination. The biventer cervicis muscles were removed and
mounted under a tension of 0.5 g, in a 5 mL organ bath (Automatic
organ multiple-bath LE01 Letica Scientiﬁc Instruments. Barcelona,
Spain) at 37 °C containing aerated (95% O2–5% CO2) Krebs solution
(pH 7.5) of the following composition (mM): NaCl 118.7, KCl 4.7,
CaCl2 1.88, KH2PO4 1.17, MgSO4 1.17, NaHCO3 25.0 and glucose 11.65.
Contracture to exogenously applied acetylcholine (ACh; 110 μM for
60 s) and KCl (20 mM for 130 s) was obtained in the absence of ﬁeld
stimulation, before and after of addition of a single dose of whole
venom (20, 50 μg/mL) or PhTX-I PLA2 (0.35, 0.7, 1.4 and 3.5 μM). A
bipolar platinum ring electrode was placed around the tendon, which
runs the nerve trunk supplying the muscle. Indirect stimulation was
performed with a (MAIN BOX LE 12404 Panlab s.l. Powerlab AD
Instruments Barcelona, Spain) stimulator (0.1 Hz, 0.2 ms, 3–4 V).
Muscle contractions and contractures were isometrically recorded by
force-displacement transducers (Model MLT0201 Force transducer
5 mg–25 g Panlab s.l. AD Instruments Pty Ltd. Spain) connected to a
PowerLab/4SP (OUAD Bridge AD Instruments, Barcelona, Spain).
2.11. Myotoxic activity
Groups of ﬁve Swiss mice (18–20 g) received an intramuscular
(i.m.) injection of variable amounts of whole venom or PhTX-I PLA2
(10 and 20 μg), in 100 μL of PBS, in the gastrocnemius. A control group
received 100 μL of PBS (0.12 M NaCl, 0.04 M sodium phosphate, pH
7.2). At different intervals of time (1, 3, 6, 9 and 24 h) blood was
collected from the tail into heparinized capillary tubes, and the plasma
creatine kinase (CK; EC 2.7.3.2) activity was determined by a kinetic
assay (Sigma 47-UV). Activity was expressed in U/l, one unit deﬁned
as the phosphorylation of 1 μmol of creatine/min at 25 °C.
2.12. Cytotoxic activity
Cytotoxic activity was assayed on murine skeletal muscle C2C12
myoblasts and myotubes (ATCC CRL-1772). Variable amounts of
whole venom and PhTX-I PLA2 (5, 10, 20 and 40 μg) were diluted in
assay medium (Dulbecco's Modiﬁed Eagle's Medium supplemented
with 1% fetal calf serum) and added to cells in 96-well plates, inFig. 1. Elution proﬁle of P. hyoprora venom by RP-HPLC on a μ-Bondapack C18 column. *Frac
on RP-HPLC of PhTX-I. Electrophoretic proﬁle in Tricine SDS–PAGE (1) molecular mass mar150 μL. Controls for 0 and 100% toxicity consisted of assay medium,
and 0.1% Triton X-100, respectively. After 3 h at 37 °C, a supernatant
aliquot was collected for determination of lactic dehydrogenase (LDH;
EC 1.1.1.27) activity released from damaged cells, using a kinetic assay
(Wiener LDH-P UV). Experiments were carried out in triplicate.2.13. Edema-forming activity
The ability of whole venom and PhTX-I PLA2 to induce edema was
studied in groups of ﬁve Swiss mice (18–20 g). Fifty microliters of
phosphate-buffered saline (PBS; 0.12 M NaCl, 0.04 M sodium phos-
phate, pH 7.2) with toxins (0.5, 1 and 2 μg/paw) were injected in the
subplantar region of the right footpad. The left footpad received 50 μL
of PBS, as a control. The paw volume was evaluated plethysmograph-
ically (Model 7140 Plethysmometer Ugo Basile, USA), immediately
before the injection (basal) and at selected intervals of time (0.5, 1, 3, 6,
9 and 24 h). Edema-forming activity was expressed as the percentage
of increase in volumeof the right foot pad in comparison to the left foot
pad (control). The formula for calculation of the percentage of edema
in toxins injected paw was %edema=[(Tx×100)/To)−100], where
Tx is the edema (volume)measured at each time interval and To is the
volume of the paw (intact, zero time before toxins injection). The
percentage of edema calculated was subtracted from the matched
values at each time point in the saline injected hind paw (control).2.14. Quantiﬁcation of Interleukin-6
Groups of ﬁve Swiss mice (18–20 g) received an injection of 10 μg
of whole venom and PhTX-I PLA2 at the tibial muscle. Blood samples
were collected into heparinized capillaries in 1, 3, 6 and 9 h after
injection. Brieﬂy, 96-well plates were coated with 100 μL of the ﬁrst
capture monoclonal antibody anti-IL-6 and incubated for 2 h at 37 °C.
Abs at 450 nmwas recorded and concentrations of IL-6were estimated
from standard curves prepared with recombinant IL-6.2.15. Statistical analyses
Results were reported as mean±SEM. The signiﬁcance of differ-
ences among means was assessed by analysis of variance followed by
Dunnett's test, when several experimental groups were compared
with the control group. Differences were considered statistically
signiﬁcant if pb0.05.tion 10 (PhTX-I PLA2) contained PLA2 and myotoxic activity. Insert: re-chromatography
kers; (2) PhTX-I not reduced; (3) PhTX-I reduced with DTT (1 M).
Table 1
Parameters of PhTX-I PLA2 puriﬁcation.
Step Volume Protein Activity Total activity Speciﬁc activity Recovery Puriﬁcation
(mL) (mg/mL) (U/mL) (U.T.) (U/mg) (%)
Crude venom 20 0.9154 274.5 5490 299.87 100 1
(HPLC) PhTX-I 1 0.0018 735 735 408,333.3 13.39 1361.7
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3.1. Puriﬁcation and biochemical characterization of the PhTX-I PLA2
Fractionation of P. hyoprora venom by RP-HPLC on a μ-Bondapack
C18 column resulted in twenty peaks (1–20) (Fig. 1). The 20 peaks
were screened for myotoxic and PLA2 activities. Peaks 10, 11 and 12
caused local myotoxicity at concentrations ranging from 5 to 20 μg/mL
in the mouse gastrocnemius muscle. In addition, peak 10, named
PhTX-I (P. hyoprora toxin 1) showed high PLA2 activity (14,5 nmoles/
min/mg) and was selected for biochemical and pharmacological
characterization. This rapid procedure showed high yield, with high
purity levels (Table 1). The purity of this peak was conﬁrmed by
rechromatography on an analytical RP-HPLC μ-Bondapack C18
column, showing the presence of only one peak and by Tricine SDS-
PAGE, that revealed the presence of one electrophoretic band withMr
around15 kDa (Fig. 1, inset), in the absence andpresence ofDTT (1 M).
MALDI-TOF mass spectrometry analysis conﬁrmed the homogene-
ity of the peak PhTX-I and determined the exact molecular mass of
14249.22 Da, the MH+, MH2+ and 2MH+ species are also shown
(Fig. 2). This value ofmolecularmasswas used in calculating themolar
concentrations of toxin used in the experiments described below.
The mass of the PhTX-I PLA2 after reducing and alkylation was
15061.2 Da (Fig. 2 insert), since the Cys is the favorite site of
alkylation, the mass increasing of 812 Da indicated the presence of 14
Cysmodiﬁed residues. In agreementwith this, the presence of 14 half-
Cys residues involved in disulﬁde bond formation is fully conserved
in this group of proteins. This suggested the occurrence of seven
disulﬁde bonds as a typical characteristic for group II of PLA2.
Amino acid analysis revealed the following composition of PhTX-I
PLA2: D/11, T/9, S/7, E/9, P/4, G/11, A/5, C/14, V/4, M/3, I/5, L/7, Y/11, F/
5, K/7, H/3 and R/10. PhTX-I PLA2 showed a high content of K, Y, G and
P residues-typical of a basic PLA2 protein.Fig. 2. Mass determination of the native PhTX-I PLA2 by MALDI-TOF mass spectrometry. Th
mass spectrum, showing multiple alkylation channels of alkylated PhTX-I PLA2 isolated from3.2. Determination of the amino acid sequences of the PhTX-I PLA2
The alkylated protein was digested with trypsin and the resulting
tryptic peptides (18) were fractionated by RP-HPLC (not shown data).
De novo sequencing by ESI-MS/MS was carried out for each peptide
peak. The data obtained were processed using the Mascot MS/MS Ion
Search software (www.matrixscience.com). Table 2 shows the
deduced sequence and measured masses of alkylated peptides
obtained for PhTX-I PLA2. Isoleucine and leucine residues were not
discriminated in any of the sequences reported since they were
indistinguishable in low energy CID spectra. Because of the external
calibration applied to all spectra, it was also not possible to resolve the
0.036 Da difference between glutamine and lysine residues, except for
the lysine that was deduced based on the cleavage and missed
cleavage of the enzyme. Each de novo sequenced peptide of the PhTX-
I PLA2 was submitted to the NCBI database, using the protein search
program BLAST-p with the search being restricted to the sequenced
proteins from the basic protein with phospholipase A2 activity family.
The primary structure of the PhTX-I PLA2 (Fig. 3) was determined
by comparing the sequences of the overlapping alkylated tryptics 18
peptides puriﬁed and sequencing from the above digests. The tandem
mass spectra shown in Fig. 4, relative to the peptide 8 of the digest,
having the sequence C C F V H D C C R, allows to classify the protein as
D49-PLA2.
The results of the primary structures show that PhTX-I PLA2 is
composed of 123 amino acid residues and shares the conserved
sequence domains common to D49 PLA2 group, including the 14
cysteines, the calcium-binding site located on (Y)27, (G)29, (G)31,
(G)32, the catalytic network common formed by (H)48, (D)49, (Y)52
and (D)89. The PhTX-I PLA2 revealed the presence of some important
amino acid replacements (S)1→(D)1; (Q)4→(E)4; (Q)7→(K)7;
(R)34→(G)34; (R)70→(W)70; I(86)→(L)86; (D)118→(A)118. A
comparative analysis of the sequence of PhTX-I PLA2 with othere MH+, MH2++ and 2MH+ species are shown in the mass spectrum. Insert MALDI-TOF
P. hyoprora.
Table 2
Measured molecular masses and deduced amino acid sequences obtained by ESI-MS/
MS based on the alkylated tryptic peptides of PhTX-I PLA2. The peptides were separated
by RP-HPLC and sequenced by mass spectrometry. C = alkylated cysteine, lysine
residues shown in bold were deduced on the cleavage and missed cleavage by trypsin.
All molecular masses are reported as monoisotopic.
HPLC fraction Measured mass (Da) Amino acid sequence
1 1312.38 ENI/LGTYNK/QK/QYR
2 1547.52 GAYGCYCGWGGRGK
3 1763.75 DPCK/QEI/LCECDK/QAAAV
4 503.18 MI/LI/LK
5 2102.91 KI/LTGCPK/QTNDRYSYSWK
6 671.28 GK/QPK/QDK
7 918.39 MI/LI/LK/QETGK
8 1384.54 CCFVHDCCR
9 2042.64 DK/QTDDRCCFVHDCCR
10 797.19 NPFPYY
11 1840.82 AAAVCFRENI/LGTYNK/QK
12 884.41 GRGK/QPK/QDK
13 1204.55 SI/LCK/QK/QADK/QPC
14 893.32 DI/LWEFGK
15 1883.76 ETGK/QNPFPYYGAYGCY
16 1650.77 K/QYRYHI/LRSI/LCK/QK
17 1160.44 I/LTGCPK/QTNDR
18 2793.06 TNDRYSYSWK/QDI/LTI/LVCGEDDPCK
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44.3–90.9% (Fig. 5).
3.3. Activity measurements of the PhTX-I PLA2
The PLA2 activity of P. hyoprora venom and PhTX-I PLA2 was
examined using the substrate 4-nitro-3-(octanoyloxy) benzoic acid.
The PLA2 speciﬁc activity of the puriﬁed protein (14.69 nmoles/min/
mg) was higher than that of the whole venom (5.49 nmoles/min/mg)
(Fig. 6A). Under the conditions used, PhTX-I PLA2 showed a discrete
sigmoidal behavior, mainly at low concentrations (Fig. 6B). Vmax and
Km were calculated to be 11.76 nmoles/min/mg and 1.96 mM,
respectively. Maximum enzyme activity occurred at 40 °C (Fig. 6C)
and the pH optimum was pH 8.0 (Fig. 6D). The PhTX-I PLA2 showed a
strict dependence on calcium ions (10 mM) for full activity. The
addition of Mg2+, Mn2+, Cd2+ and Zn2+ (10 mM) in the absence or
presence of low Ca2+ concentration (1 mM) signiﬁcantly decreases
the enzyme activity (Fig. 6E).
3.4. Pharmacological activities of the P. hyoprora venom and PhTX-I PLA2
The chick biventer cervicis nerve–muscle preparationwas used as a
convenient test for the pharmacological activity of P. hyoprora venom
and PhTX-I PLA2. Whole venom concentrations of 20 and 50 μg/mL asFig. 3. Determination of the complete amino acid sequence of PhTX-I PLA2, deduced by overla
The peptides were separated by RP-HPLC.well as 0.35, 0.7, 1.4 and 3.5 μM of PhTX-I PLA2 were tested on
indirectly stimulated preparations. Both caused a slow, progressive
decrease in the twitch responses to nerve stimulation (Fig. 7A–D). The
time required by venom to cause 50% twitch tension blockade was
19.7±3.8 min (50 μg/mL), 74.6±5.9 min (20 μg/mL). The time
required by PhTX-I PLA2 to cause 50% blockade was about 15.8±1.5,
22.5±2.1, 33.8±3.6 min at the concentration tested (3.5, 1.4, 0.7 μM
respectively). Lower concentration (0.35 μM)was not as effective and
did not reach 50% within 120 min. (Fig. 7B). Whole venom (20 and
50 μg/mL) and higher concentrations of PhTX-I PLA2 (1.4 and 3.5 μM)
decreased the contractures induced by acetylcholine and KCl after
120 min. In lower concentrations (0.35 and 0.7 μM), contractures to
exogenous acetylcholine and KCl were still seen after PhTX-I PLA2-
induced blockade (Fig. 7E–F).
As shown in Fig. 8A and B, whole venom and PhTX-I PLA2,
respectively, induced a conspicuous local myotoxic effect, evidenced
by dose-dependent elevation of plasma CK. The highest activity was
found with 20 μg/mouse of PhTX-I PLA2 (Fig. 8A) with activity similar
to that seen for the whole venom (20 μg) (Fig. 8B). The time-course
analysis evidenced rapid activity, which reached a maximum increase
3–6 h after i.m. injection, and returned to normal by 24 h.
Doses of 5 and 10 μg/150 μL of whole venom and PhTX-I PLA2 show
a slight cytolytic effect when were tested against C2C12 skeletal
muscle myoblastos, (Fig. 8C). The toxin PhTX-I lysed myotubes at
doses from 5 to 40 μg/well, since the whole venom induced the same
effect at doses 10–40 μg/well (Fig. 8D).
The subplantar injection of either P. hyoprora venom (1–2 μg/paw)
or PhTX-I (0.5–1 μg/paw) induced moderated paw oedema. The paw
oedema induced by crude venom and PhTX-I had a similar time-
course proﬁle as characterized by a rapid onset (maximal responses
obtained at 30 min post-injection) and returned to normal levels after
24 h (Fig. 8E). To further analyze and compare the mechanism of the
inﬂammatory events induced by P. hyoprora venom and puriﬁed
PhTX-I PLA2 (Fig. 8F), the concentrations of IL-6 in the plasma were
measured. Both, whole venom and PhTX-I PLA2 (10 μg), caused a
marked increased in IL-6 levels, reaching maximum increase 3 h after
the injection when compared to the control. Six hours after the
injection, there was a decrease of the IL-6 levels.
4. Discussion
PLA2 are among the most abundant components of snake venoms,
showing a wide range of activities even presenting conserved
structures (Kini, 2003; Magro et al., 2004; Tsai et al., 2004).
Understanding the structural basis for their diverse toxic activities,
including neurotoxicity and myotoxicity, is still a challenging task. In
this work, the ﬁrst biochemical and toxinological characterization of
the new PLA2 from the venom of P. hyoprora here named PhTX-I, is
reported.pping of the sequence of peptides obtained by tryptic digesting of the alkylated protein.
Fig. 4. ESI-QTOF-MS/MS spectrum of the tryptic peptide of 1312.38 Da. Series of y fragment ions of 9-residue-long tryptic peptide eluted in fraction 8 of the RP-HPLC of the alkylated
PhTX-I PLA2 containing the aspartic acid residue at position 49 in the amino acid sequence.
113S. Huancahuire-Vega et al. / Comparative Biochemistry and Physiology, Part C 154 (2011) 108–119The work group has been optimizing and standardized the method-
ology of puriﬁcation of PLA2 of snake venom in a single step
chromatographic in a column μ-Bondapack C-18 coupled to a system of
reverse phase HPLC, as a result of the proposed method, several toxinsFig. 5. Alignment of the deduced amino acid sequence of the PhTX-I PLA2 with D49-PLA2. Braz
from Bothrops jararacussu (Ponce-Soto et al., 2006); BmTX-I from Bothrops moojeni (Calgaro
2010); LmTX-I from Lachesis muta muta (Damico et al., 2005).have been efﬁciently puriﬁed (Calgarotto et al., 2008; Randazzo-Moura et
al., 2008; Huancahuire-Vega et al., 2009; Ponce-Soto et al., 2010; Romero-
Vargas et al., 2010). The puriﬁcation procedure herein described was
efﬁcient for the obtainment of the newPhTX-I PLA2 toxin from P. hyoprorailitoxin III (BbTX-III) from Bothrops brazili (Huancahuire-Vega et al., 2009); 6_1 and 6_2
tto et al., 2008); BmjeTX-I and BmjeTX-II from Bothrops marajoensis (Ponce-Soto et al.,
Fig. 6. (A) PLA2 activity of P. hyoprora venom and PhTX-I PLA2 (B) Effect of substrate concentration on the PLA2 activity of PhTX-I. Insert: details in low substrate concentrations;
(C) Effect of pH on the PLA2 activity of PhTX-I; (D) Effect of temperature on the PLA2 activity of PhTX-I; (E) Inﬂuence of ions (10 mM each) on PLA2 activity of PhTX-I in the absence or
presence of 1 mM Ca2+. The results of all experiments are the mean±SEM of three determinations (pb0.05).
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producing 8–15 mg of the toxin and high purity levels (Table 1).
A great number of PLA2 isolated from the venoms of Bothrops sp
are oligomers constituted by two or more subunits (Magro et al.,
2009), nevertheless, Tricine SDS-PAGE showed (Fig. 1inset) thatPhTX-I PLA2, have one band with Mr ~15 kDa, being a protein
constituted of a single polypeptidic chain. Brazilitoxin III of Bothrops
brazili (Huancahuire-Vega et al., 2009), blD-PLA2 of Bothrops leucurus
(Higuchi et al., 2007) and LmTX-I of Lachesis muta muta (Damico et al.,
2005) are D49-PLA2 that also have structure monomeric.
Fig. 7. Neuromuscular blockade of chick biventer cervicis preparations incubated with P. hyoprora venom and PhTX-I PLA2 at 37 °C. The points are the mean±SEM of six
experiments. *pb0.05 compared to the twitch-tension before P. hyoprora venom (A) and PhTX-I PLA2 (B) addition. Panels C and D shows a representative recording from a
preparation treated with 50 μg of P. hyoprora venom and 0.7 μM of PhTX-I PLA2, respectively. Tissue responses to KCl (■, 20 mM) and acetylcholine (ACh, ●, 110 μM) were obtained
before and after toxins addition. Panels E and F shows the effect of P. hyoprora venom and PhTX-I PLA2, respectively, on muscle contractures evoked by KCl and acetylcholine (ACh).
Each point is the mean±SEM of six experiments. *pb0.05 compared to the control (pre-toxin) contractures (100%).
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similar to that of other snake venom PLA2 (Fig. 2) (Ponce-Soto et al.,
2007, 2010; Perumal et al., 2008; Garcia et al., 2010). The amino acid
composition of thePhTX-I PLA2 toxin suggest thepresence of 14half-Cys
residues, provided the basis for a common structural feature of PLA2 in
the formation of its seven disulﬁde bridges (Gutiérrez and Lomonte,
1995, 1997; Ponce-Soto et al., 2007; 2010) and a high content of basic
and hydrophobic residues, that provides a clue point the interaction of
the PLA2 with negatively charged phospholipids of cells membranes
(Murakami andArni, 2003). Such interaction is important to explain the
effect of these enzymes on different cells types, both prokaryotes and
eukaryotes (Lomonte et al., 1999; Kini, 2003).Comparison of the amino acid sequence of PhTX-I PLA2 showed
high homology with others myotoxin PLA2 from the genus Bothrops
(Fig. 5). One of the highly conserved regions in the amino acid
sequences of PLA2 is the Ca2+-binding loop, segment from (Y)24 to
(G)35, that contains four glycine residues at positions 26, 30, 32, and
33, and two cysteine residues at positions 27 and 29. The calcium ion
is coordinated by threemain chain oxygen atoms from residues (Y)28,
(G)30, (G)32, and two carboxylate oxygen atoms of (D)49. Two
generally conserved solvent water molecules complete the coordina-
tion sphere of the calcium ion forming a pentagonal bipyramidal
geometry. It is believed that two disulﬁde bridges (C)27–(C)119 and
(C)29–(C)45 ensure the correct relative orientation of the calcium
Fig. 8. (A) Time-course of the increments in plasma CK activity after intramuscular injection of P. hyoprora venom (10 and 20 μg) and (B) PhTX-I PLA2 (10 and 20 μg). Controls were
injected with 100 μl of PBS. At different times, blood was collected, and serum levels were measured. Values are means±SEM of ﬁve mice at each time point. (C) In vitro cytotoxic
activity of P. hyoprora venom and PhTX-I PLA2 onmurine C2C12 skeletal muscle myoblasts and (D)myotubes. Cell lysis was estimated by the release of lactic dehydrogenase (LDH) to
supernatants, after 3 h of exposure to the toxin, in a volume of 150 μL/well. Each point represents mean±SEM of triplicate cell cultures. (E) Edema-forming activity of P. hyoprora
venom (1, 2 μg) and PhTX-I PLA2 (0.5, 1 μg) in mice. Induction of edema by toxins, injected s.c. in the footpad of mice. At various time intervals the increase in footpad volume, as
compared to controls, was expressed as percent edema. Each point represents the mean±SEM of ﬁve animals. (F) Systemic interleukin-6 response induced by 10 μg of P. hyoprora
venom and PhTX-I PLA2 in mice. Plasma levels of IL-6 were determined at the indicated time points, by enzyme immunoassay. Each point represents ±SEM of ﬁve mice.
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(Scott et al., 1990). The residues (H)48, (Y)52 and (D)99 which are
responsible for catalytic activity have an ideal stereochemistry with
the presence of the so called “catalytic network”, a system of hydrogen
bonds which involves the catalytic triad (Scott et al., 1990). Residues
forming the Ca2+-binding loop and the catalytic network of PhTX-I
PLA2 show a high conservation grade, reﬂecting the non-decreased
catalytic activity.
In a similar way, the PhTX-I PLA2 showed a complete overlap with
other class II PLA2 for the invariant hydrophobic side-chains of (L)2,(W/F)3, (I)9, (Y)22, (C)29, (C)45 and (A)93 which form the walls of
the hydrophobic channel for the binding of the substrate in PLA2. The
side-chains of these residues are directed towards, and thus might
interact with the phospholipid layer (Singh et al., 2001).
It is well know that the N-terminal region of PLA2, which is high
conservative in catalytically active PLA2 enzymes, displays important
roles for catalysis as well as for pharmacological activities (Qin et al.,
2005). Several lines of evidence show that the amino acids (L)2, (Y)3,
(Q)4, (K)6, (I)9 (E)12 and (T)13 of the N-terminal region functionally
contributes to facilitate a productive-mode orientation of PLA2 at the
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(W)3 and (Q)4 by (E)4 in the PLA2 PhTX-I suggest that these residue
contribute to the conformational maintenance of hydrophobic pocket
at the N-terminal region, since the modiﬁcations presented in this
PLA2 do not obstruct the catalytic function, permitting the lipidic
substrate to continue to get access to PLA2 catalytic site.
Breithaupt (1976) reported that venom PLA2 shows classic
Michaelis-Menten behavior against micellar substrates. However,
the enzymatic activity of PhTX-I PLA2, against non-micellar substrate,
showed a discrete sigmoidal behavior, mainly at low concentrations
(Fig. 6B), what is in agreement with the results obtained by Pereañez
et al., 2009 for the PLA2 Cdcum6 of Crotalus durissus cumanensis
venom. Highest enzymatic activity occurs at pH 7–8 and 35–45 °C
(Fig. 6C and D), like other PLA2, PhTX-I is relatively resistant to heat
(Kini, 1997; Damico et al., 2005; Calgarotto et al., 2008). Due to its
ectothermic nature, the variation of the corporal temperature of the
reptiles affects many physiologic processes and of development
(Peterson et al., 1993). Molecules with stable structures that can
maintain its functionality front to the variations of temperature of the
environmental are necessary for the survival of the snakes.
PhTX-I PLA2 showed that the Ca2+ ion is an obligatory co-factor for
its enzymatic activity. Studies of its substitution by other divalent ions
(Mg2+, Mn2+, Cd2+, and Zn2+) were not able to keep the substrate
bound to the enzyme, only Ca2+ supports the catalytic activity
(Fig. 6E). This can be explained by different coordination geometries
assumed by the tetrahedral intermediate due to the presence of the
Ca2+ ion which determine the electrophilic behavior of the catalytic
site, as well as stabilizes the otherwise ﬂexible Ca2+-binding loop and
appears to optimize the local protein conformation for substrate
interactions (Scott et al., 1990; Yu et al., 1993). Other metals fail to
productively bind to the enzyme, competitively inhibit Ca2+-mediated
activity, or are weakly active (Mezna et al., 1994). Interestingly Mg2+
andMn2+ in presence of lowCa2+ concentrations support a signiﬁcant
catalytic activity.
Snakebite envenoming is a global public health problem, particu-
larly in tropical and subtropical countries. To understand how venoms
work requires quantitative data on the occurrence of individual toxins
in given venom (Calvete et al., 2009). A proﬁle of toxic activities was
investigated for PhTX-I PLA2, including ex vivo neurotoxicity and
cyototoxicity, in vivo myotoxic, and edematogenic activities.
Although “bothropic envenomation” produces no neurotoxic
clinical signs, venoms from several species can cause neuromuscular
blockade ex vivo and produce signs of peripheral muscular weakness
in chickens and mice (Oshima-Franco et al., 2004; Calgarotto et al.,
2008; Randazo-Moura et al., 2008). P. hyoprora venom and PhTX-I
PLA2 caused concentration-dependent blockade of elicited twitch
responses of the chick biventer cervicis muscle preparation at all
concentrations (Fig. 7A–D). Whole venom (20 and 50 μg/mL) reduced
response to ACh and KCl after incubation with the venom (Fig. 7E).
Such inhibition could involve damage to nicotinic receptors by the
proteas es present in this venom, as well as damage to muscle ﬁbers
(Prianti et al., 2003; Abreu et al., 2007). On the other hand, PhTX-I PLA2
(0.35 and 0.7 μM) not interfere with the muscle contractures to
exogenous ACh and KCl, indicating that the toxin had not direct action
on nicotinic receptors and muscle ﬁbers. However, using highest
concentrations (1.4 and 3.5 μM) inhibition of the responses to ACh and
KCl was observed (Fig. 7F). The fact that PhTX-I did not signiﬁcantly
affect the responses to ACh and KCl, except when high concentrations
were used, suggests that PhTX-I PLA2 presents a primordial presyn-
aptic action. Similar results were obtained for BmjeTX-I and II (Ponce-
Soto et al., 2010), BmTX-I (Calgarotto et al., 2008), LmTX-I (Damico
et al., 2005).
P. hyoprora venom and PhTX-I PLA2 increase the plasmatic CK
levels after i.m. injection (Fig. 8A and B, respectively), revealing
drastic local myotoxicity. This myotoxicity induced by snake venoms,
including P. hyoprora, may result from the direct action of myotoxinson the plasma membranes of muscle cells, or indirectly, as
consequence of vessel degenerations and ischemia caused by
hemorrhagins or metaloproteases (Prianti et al., 2003; Abreu et al.,
2007). PhTX-I PLA2 contributes signiﬁcantly to local myotoxic action
in vivo. It was already demonstrated that the snake venom PLA2 are
the principal cause of local damage (Gutierrez and Ownby, 2003).
Myotoxic PLA2 affect directly the plasma membrane integrity of
muscle cells, originating an inﬂux of Ca2+ ions to the cytosol that
starts several degenerative events with irreversible cell injures
(Montecucco et al., 2008). The binding sites of myotoxins on the
plasma membranes are not clearly established, although two types
have been proposed: (a) negatively charged phospholipids (Diaz
et al., 2001), present on membranes of several cell types, explaining
the high in vitro cytotoxic action of these enzymes (Angulo and
Lomonte, 2005), and (b) protein receptors, which make muscle cells
more susceptible to myotoxin action (Lomonte et al., 1999).
Whole venom and PhTX-I PLA2 did not show cytotoxic effect in
skeletal muscle of myoblasts in a dosage of 5 to 10 μg/well. However
an increased susceptibility of the myotubes was clearly observed
using the PhTX-I PLA2 toxin (Fig. 8C and D). This fact is probably due
to the ability of this toxin in disturbing the membrane, and seems to
involve the expression of a huge number of acceptors or a high
acceptors site afﬁnity for the PLA2 plasmatic membrane. It is not
possible to assert which would be the acceptors or which speciﬁc
region/residue of PhTX-I PLA2 would be involved or even which
interactions would be involved in the process. However, the possible
participation of intracellular processes arising after myoblast fusion,
as seen in the enhanced damage to myotubes, cannot be excluded at
this time (Angulo and Lomonte, 2005). High concentration of whole
venom and PhTX-I PLA2 (20, 30 and 40 μg/well) caused a signiﬁcant
cytotoxicity in myoblasts and myotubes, probably due to links with
non-speciﬁed tubes.
Bothrops snake venoms induce local edema in humans and
experimental animals (Kini, 1997). The acute inﬂammatory reaction
is characterized by exudation of ﬂuid and plasma proteins leading to a
local edema formation. P. hyoprora venom and PhTX-I PLA2 induced
paw edema in mice increasing the microvascular permeability. This
activity was time-dependent and it reached the maximum answer in
the ﬁrst 30 min (Fig. 8E). The edema formation induced by P. hyoprora
venom was similar to that of other bothropic venoms, including
Bothrops asper (Chaves et al., 1995, 1998; Teixeira et al., 2009),
Bothrops insularis (Barbosa et al., 2003) and Bothrops lanceolatus (de
Araujo et al., 2000).
PLA2 are multifunctional proteins able to participate in inﬂamma-
tory processes since they provide precursors for pro-inﬂammatory
lipid substances such as arachidonic acid-derived mediators and PAF
(Teixeira et al., 2003). Our results shown that PhTX-I PLA2 induces
increased edema formation in mouse paw in the samemagnitude that
the whole venom (Fig. 8E), suggesting that at least part of the
inﬂammatory actions of crude venom is due to PhTX-I PLA2. Other
venom components, such as metalloproteinases or lectins may also
contribute to the edematogenic properties of crude venom. Studies
have been directed trying to understand the mechanisms involved in
the inﬂammatory response induced by myotoxic PLA2 from several
snake venoms (Teixeira et al., 2003). However, the relationship
between enzymatic activity and edema is contradictory (Vishwanath
et al., 1987). It is assumed that myotoxic and edematogenic activities
can be induced by different structural domains in these PLA2, or that a
partial overlapping of these domains occurs (Zuliani et al., 2005).
There was an increase of IL-6 levels after the injection PhTX-I PLA2
and P. hyoprora venom (Fig. 8F). Myonecrosis might be the trigger for
the systemic release of the proinﬂammatory cytokine IL-6 observed,
in agreement with earlier ﬁndings with B. aspermyotoxin II (Lomonte
et al., 1993) and Bothrops moojeni BmTX-I (Calgarotto et al., 2008).
IL-6 is a main signal multifunctional cytokine involved in the
regulation of the immune response, hematopoiesis, and inﬂammation
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envenomations by Bothrops species (Avila-Aguero et al., 2001).
In conclusion, we report the ﬁrst PLA2 from P. hyoprora snake
venom, the study show that PhTX-I, is a monomeric new D49-PLA2
which displays the major toxic actions reported for this type of
proteins, including local myotoxicity, neurotoxicity, cytotoxicity, pro-
inﬂammatory activity and probably has a principal role in envenom-
ings by this snake species. The elucidation of its complete primary
structure, here reported, will be of value in future comparative studies
attempting to identify the molecular determinants of toxic activities
by other basic PLA2 in viperid venoms.
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